Replimune Group, Inc.
500 Unicorn Park Drive
Woburn, MA 01801
July 27, 2022
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549-6010
|Re:||Replimune Group, Inc. Registration Statement on Form S-3 Filed June 23, 2022 (Registration No. 333-265805)|
Dear Mr. Crawford:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced Registration Statement (the “Registration Statement”) of Replimune Group, Inc. We respectfully request that the Registration Statement become effective as of 4:05 p.m., Eastern time, on July 27, 2022, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Benjamin J. Stein at +1 (781) 724-4258.
[Remainder of page intentionally left blank]
|Very truly yours,|
|Replimune Group, Inc.|
|Chief Financial Officer|
|cc:||Philip Astley-Sparke, Replimune Group, Inc.|
|Shawn Glidden, Replimune Group, Inc.|
|Timothy J. Corbett, Morgan, Lewis & Bockius LLP|